Streetbeat News

ZJYL

Jin Medical International Ltd.

https://www.zhjmedical.com

Industry

Medical - Instruments & Supplies

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

Open

0.76

Mkt cap

133M

Volume

264K

High

0.89

P/E Ratio

42.50

52-wk high

16.60

Low

0.76

Div yield

N/A

52-wk low

0.70

In Monday's after-market session, several healthcare stocks experienced significant movements. Jin Medical International (ZJYL) saw a substantial increase of 72.5%, while NRX Pharmaceuticals (NRXP) led the losers with a 12.1% decrease. Other notable gainers include Panbela Therapeutics (PBLA), IN8bio (INAB), Reviva Pharmaceuticals (RVPH), CNS Pharma (CNSP), and Nexalin Technology (NXL). On the losing side, bluebird bio (BLUE), Senti Biosciences (SNTI), Motus GI Holdings (MOTS), Zura Bio (ZURA), and BioAtla (BCAB) also saw declines.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 9:31 pm

Lantheus Holdings, Inc. (LNTH) shares fell by over 22% after announcing topline results from a phase 3 study with POINT Biopharma. Other stocks moved in Monday's mid-day session with notable gainers and losers across various sectors. United States Steel Corporation (X) rose after an acquisition announcement by Nippon Steel, while Ebix, Inc. (EBIX) shares plummeted following a Chapter 11 filing and asset sale agreement.

Portfolio Pulse from Avi Kapoor

December 18, 2023 | 6:05 pm

JinMed's stock price has declined following the announcement of a preliminary memorandum of understanding to potentially acquire a full or partial stake in Zhongjin Kanglu.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 4:23 pm

JIN MEDICAL INTERNATIONAL LTD. (NASDAQ:ZJYL), a manufacturer of wheelchairs and living aids, has signed an MOU to potentially acquire Jiangsu Zhongjin Kanglu Information Technology Co., Ltd., a medical equipment sharing platform. The due diligence process is expected to be completed by December 31, 2023, with detailed negotiations starting in March 2024. Zhongjin Kanglu's shared medical equipment is used in over 1,600 hospitals in China. The acquisition aims to create synergies and promote JinMed's products in China.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 1:35 pm

Jin Medical International Ltd. (NASDAQ:ZJYL) has announced its portable nano-thermal therapy bath has been selected for the 'Lao Le Hui' Assisted Bathing Project in Shanghai, aimed at serving 100,000 elderly individuals. The company will provide 1,000 sets of this equipment, which uses nano-water particle thermal therapy technology to offer a comfortable bathing experience without immersion. The project, supported by various partners, will also train 2,000 bathing attendants and aims to enhance elderly care services.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 1:41 pm

ReShape Lifesciences Inc. (RSLS) shares soared by approximately 45% in pre-market trading due to FDA PMA supplement approval for its Lap-Band 2.0 FLEX. Other stocks also experienced significant movement in pre-market trading, with various gainers such as RiskOn International, Inc. (ROI) and C4 Therapeutics, Inc. (CCCC), and losers including Jin Medical International Ltd. (ZJYL) and Altisource Asset Management Corporation (AAMC).

Portfolio Pulse from Avi Kapoor

December 13, 2023 | 12:55 pm

JIN MEDICAL INTERNATIONAL LTD. (NASDAQ:ZJYL) has secured orders worth approximately $9.18 million for its innovative Micro-Hyperbaric Oxygen Chamber equipment from Conlo Industrial Development Co., Ltd. The order includes 200 units each of S-type and M-type chambers, with Conlo planning to deploy 20,000 oxygen chambers in the Chinese market over the next three years. The company's CEO, Mr. Erqi Wang, highlighted the breakthrough in medical technology and the trust in JinMed's commitment to healthcare excellence.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 1:48 pm

Chinese stocks are experiencing an uptick following China's decision to maintain its one-year and five-year loan prime rates for November. The positive sentiment is further bolstered by reports of Chinese regulators promising additional support for the property sector.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 4:12 pm

In Friday's pre-market session, several healthcare stocks experienced significant movement. Apollomics (APLM), SeaStar Medical Holding (ICU), CVRx (CVRX), ABVC BioPharma (ABVC), DexCom (DXCM), and Jin Medical International (ZJYL) saw gains, while TransCode Therapeutics (RNAZ), PTC Therapeutics (PTCT), Pasithea Therapeutics (KTTA), Sanofi (SNY), PaxMedica (PXMD), and Nexalin Technology (NXL) experienced losses. Q3 earnings reports were recently released for CVRx, DexCom, PTC Therapeutics, and Sanofi.

Portfolio Pulse from Benzinga Insights

October 27, 2023 | 1:05 pm

Several healthcare stocks experienced significant price movements during Monday's intraday session. Acurx Pharmaceuticals, Turnstone Biologics, Jin Medical International, ContraFect, Freeline Therapeutics, and RVL Pharmaceuticals saw their stock prices increase, while SeaStar Medical Holding, Addex Therapeutics, Etao International Co, Longeveron, Vaccinex, and Tango Therapeutics experienced declines.

Portfolio Pulse from Benzinga Insights

October 09, 2023 | 5:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.